These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31100388)

  • 1. Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.
    Grein F; Schneider T; Sahl HG
    J Mol Biol; 2019 Aug; 431(18):3520-3530. PubMed ID: 31100388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid II as a target for antibiotics.
    Breukink E; de Kruijff B
    Nat Rev Drug Discov; 2006 Apr; 5(4):321-32. PubMed ID: 16531990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding role of lipid II as a target for lantibiotics.
    Martin NI; Breukink E
    Future Microbiol; 2007 Oct; 2(5):513-25. PubMed ID: 17927474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II.
    Oppedijk SF; Martin NI; Breukink E
    Biochim Biophys Acta; 2016 May; 1858(5):947-57. PubMed ID: 26523408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting a cell wall biosynthesis hot spot.
    Müller A; Klöckner A; Schneider T
    Nat Prod Rep; 2017 Jul; 34(7):909-932. PubMed ID: 28675405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway.
    Schneider T; Sahl HG
    Int J Med Microbiol; 2010 Feb; 300(2-3):161-9. PubMed ID: 20005776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
    Hasper HE; Kramer NE; Smith JL; Hillman JD; Zachariah C; Kuipers OP; de Kruijff B; Breukink E
    Science; 2006 Sep; 313(5793):1636-7. PubMed ID: 16973881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics.
    Stegmann E; Frasch HJ; Kilian R; Pozzi R
    Int J Med Microbiol; 2015 Feb; 305(2):190-5. PubMed ID: 25601631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting bactoprenol-coupled cell envelope precursors.
    Ulm H; Schneider T
    Appl Microbiol Biotechnol; 2016 Sep; 100(18):7815-25. PubMed ID: 27495122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial mechanism of lantibiotics.
    Islam MR; Nagao J; Zendo T; Sonomoto K
    Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.
    Schmitt P; Wilmes M; Pugnière M; Aumelas A; Bachère E; Sahl HG; Schneider T; Destoumieux-Garzón D
    J Biol Chem; 2010 Sep; 285(38):29208-16. PubMed ID: 20605792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.
    Brötz H; Bierbaum G; Reynolds PE; Sahl HG
    Eur J Biochem; 1997 May; 246(1):193-9. PubMed ID: 9210483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics.
    de Kruijff B; van Dam V; Breukink E
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):117-21. PubMed ID: 19008088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate analogues to study cell-wall biosynthesis and its inhibition.
    Lazar K; Walker S
    Curr Opin Chem Biol; 2002 Dec; 6(6):786-93. PubMed ID: 12470732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides.
    Münch D; Sahl HG
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
    Schneider T; Sahl HG
    Curr Opin Investig Drugs; 2010 Feb; 11(2):157-64. PubMed ID: 20112165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Insights into the Mode of Action of the Peptide Antibiotic Copsin.
    Franzoi M; van Heuvel Y; Thomann S; Schürch N; Kallio PT; Venier P; Essig A
    Biochemistry; 2017 Sep; 56(37):4992-5001. PubMed ID: 28825809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Found Hope for Antibiotic Discovery: Lipid II Inhibitors.
    Ng V; Chan WC
    Chemistry; 2016 Aug; 22(36):12606-16. PubMed ID: 27388768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
    Wiedemann I; Breukink E; van Kraaij C; Kuipers OP; Bierbaum G; de Kruijff B; Sahl HG
    J Biol Chem; 2001 Jan; 276(3):1772-9. PubMed ID: 11038353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing cell wall inhibitors towards clinical applications.
    Maffioli SI; Cruz JC; Monciardini P; Sosio M; Donadio S
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):177-84. PubMed ID: 26515981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.